141 related articles for article (PubMed ID: 20937792)
1. Low tigecycline concentrations in the cerebrospinal fluid of a neutropenic patient with inflamed meninges.
Lengerke C; Haap M; Mayer F; Kanz L; Kinzig M; Schumacher U; Sörgel F; Riessen R
Antimicrob Agents Chemother; 2011 Jan; 55(1):449-50. PubMed ID: 20937792
[No Abstract] [Full Text] [Related]
2. Cerebrospinal fluid penetration of tigecycline.
Pallotto C; Fiorio M; D'Avolio A; Sgrelli A; Baldelli F; Di Perri G; De Socio GV
Scand J Infect Dis; 2014 Jan; 46(1):69-72. PubMed ID: 24131423
[TBL] [Abstract][Full Text] [Related]
3. Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.
Mukker JK; Singh RP; Derendorf H
J Pharm Sci; 2014 Mar; 103(3):1013-9. PubMed ID: 24549736
[TBL] [Abstract][Full Text] [Related]
4. Results of tigecycline trials announced.
McConnell J
Lancet Infect Dis; 2004 Dec; 4(12):717. PubMed ID: 15593443
[No Abstract] [Full Text] [Related]
5. Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective.
Curcio D
J Clin Microbiol; 2008 May; 46(5):1892-3. PubMed ID: 18460636
[No Abstract] [Full Text] [Related]
6. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
Arroyo LA; Mateos I; González V; Aznar J
Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
[No Abstract] [Full Text] [Related]
7. Tigecycline: place in therapy and important considerations.
Garrelts JC; Schroeder T
Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574
[No Abstract] [Full Text] [Related]
8. Is there a future for tigecycline?
Bassetti M; Poulakou G; Giamarellou H
Intensive Care Med; 2014 Jul; 40(7):1039-45. PubMed ID: 24871501
[No Abstract] [Full Text] [Related]
9. Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia.
Pugliese N; Salvatore P; Iula DV; Catania MR; Chiurazzi F; Della Pepa R; Cerchione C; Raimondo M; Giordano C; Simeone L; Caruso S; Pane F; Picardi M
Cancer Med; 2017 Jul; 6(7):1500-1511. PubMed ID: 28556623
[TBL] [Abstract][Full Text] [Related]
10. High serum concentrations of cyclosporin related to administration of tigecycline.
Stumpf AN; Schmidt C; Hiddemann W; Gerbitz A
Eur J Clin Pharmacol; 2009 Jan; 65(1):101-3. PubMed ID: 18795273
[No Abstract] [Full Text] [Related]
11. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
[TBL] [Abstract][Full Text] [Related]
12. Tigecycline for severe Clostridium difficile infection.
Thomas A; Khan F; Uddin N; Wallace MR
Int J Infect Dis; 2014 Sep; 26():171-2. PubMed ID: 25064460
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of tigecycline in rat brain tissues.
Munyeza CF; Shobo A; Baijnath S; Bratkowska D; Naiker S; Bester LA; Singh SD; Maguire GE; Kruger HG; Naicker T; Govender T
Biomed Chromatogr; 2016 Jun; 30(6):837-45. PubMed ID: 26378888
[TBL] [Abstract][Full Text] [Related]
14. EUCAST technical note on tigecycline.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Nov; 12(11):1147-9. PubMed ID: 17063597
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus.
Tang HJ; Chen CC; Lai CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2018 Feb; 51(1):76-81. PubMed ID: 27260781
[TBL] [Abstract][Full Text] [Related]
16. Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis.
Ray L; Levasseur K; Nicolau DP; Scheetz MH
Ann Pharmacother; 2010 Mar; 44(3):582-6. PubMed ID: 20179255
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
[TBL] [Abstract][Full Text] [Related]
18. S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis.
Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Scalise A; Gabrielli E; Scuppa D; Romiti C; Provinciali M; Guerrieri M; Giacometti A
Peptides; 2010 Jul; 31(7):1231-6. PubMed ID: 20381561
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline.
Wadi JA; Selawi F
Ann Saudi Med; 2009; 29(3):239-40. PubMed ID: 19448375
[No Abstract] [Full Text] [Related]
20. New antibiotic approved for MRSA.
Senior K
Lancet Infect Dis; 2005 Aug; 5(8):474. PubMed ID: 16094734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
